Estrogenic and progestational activity of 7α-methyl-19-nortestosterone, a synthetic androgen

Synthetic androgens exhibit estrogenic/antiestrogenic and progestational activities in addition to their androgenic effects. To investigate the pharmacological action of the synthetic androgen, 7alpha-methyl-19-nortestosterone (MENT), we examined its action in female rodents. The criteria employed for estrogenic/antiestrogenic effects were, uterine weight increase, vaginal cornification, induction of progesterone receptors (PR) synthesis and stimulation of peroxidase activity in the uteri of ovariectomized rats and mice. MENT increased uterine weight in a dose dependent manner, but did not cause vaginal cornification or stimulate PR synthesis in the uterus. The uterotropic activity of MENT was 200-fold lower than that of estradiol. Estrogen receptor (ER) bound [3H]-E2 was displaced by E2 and MENT with ED50 values of 70 pg and 250 ng, respectively, a 3,500 fold difference in their binding affinity. The low binding of MENT to ER, in contrast to its relatively high uterotropic action, suggested that receptors other than ER may be involved in its action on the uterus. The progestational activity of MENT in immature rabbits using the McPhail index assay was comparable to that of progesterone. Binding affinities of MENT and progesterone to PR were also comparable. However, the action of MENT on the uterus does not seem to be a progestational effect since mifepristone, an antiprogestin, had no effect on MENT-induced uterine growth. Specific androgen receptors (AR) in uterine cytosol were demonstrated. The involvement of AR in MENT action was confirmed by using an antiandrogen (flutamide) and an antiestrogen (ICI-182) in ovariectomized mice. Although MENT did not block the uterotropic effect of E2, it inhibited the E2-induced cornification of vaginal epithelium, induction of uterine PR synthesis and increase in uterine peroxidase activity in ovariectomized rats. The antiestrogenic effect of MENT was also blocked by flutamide. These results suggest that the uterotropic and antiestrogenic effects of androgens are mediated via AR. It is concluded that the increase in uterine weight caused by MENT is attributable to its anabolic effects.

[1]  W. Fishman,et al.  Human serum β-glucuronidase; its measurement and some of its properties , 1967 .

[2]  J. MacIndoe,et al.  Androgens inhibit estrogen action in MCF-7 human breast cancer cells. , 1980, Life sciences.

[3]  Lerner Lj HORMONE ANTAGONISTS: INHIBITORS OF SPECIFIC ACTIVITIES OF ESTROGEN AND ANDROGEN. , 1964 .

[4]  E. Gurpide,et al.  Estrogenic and progestagenic activities coexisting in steroidal drugs: Quantitative evaluation by In vitro bioassays with human cells , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[5]  H. Rochefort,et al.  The estrogenic and antiestrogenic activities of androgens in female target tissues. , 1983, Pharmacology & therapeutics.

[6]  R. Hochberg,et al.  Intrinsic estrogenicity of some progestagenic drugs , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  C. Bardin,et al.  7 alpha-methyl-nortestosterone (MENT): the optimal androgen for male contraception. , 1993, Annals of medicine.

[8]  S. Himmelhoch,et al.  Purification of myeloperoxidases from the bone marrow of the guinea pig. , 1969, Biochemistry.

[9]  A. E. Lemus,et al.  Induction of male sexual behavior in the rat by 7 alpha-methyl-19-nortestosterone, an androgen that does not undergo 5 alpha-reduction. , 1993, Biology of reproduction.

[10]  J. Morley,et al.  Biological actions of androgens. , 1987, Endocrine reviews.

[11]  W. L. Hunt,et al.  Sexual activity in castrated male rabbits after oral administration of 7 alpha-methyl-19-nortestosterone 17-(1-adamantoate). , 1973, Physiology & behavior.

[12]  R. Edgren,et al.  A biological classification of progestational agents. , 1967, Fertility and sterility.

[13]  B. Katzenellenbogen,et al.  Androgen-uterine interactions: An assessment of androgen interaction with the testosterone- and estrogen-receptor systems and stimulation of uterine growth and progesterone-receptor synthesis , 1979, Molecular and Cellular Endocrinology.

[14]  D. Rodbard,et al.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. , 1978, The American journal of physiology.

[15]  U. Kim,et al.  Androgen control of cytosol progesterone receptor levels in the MT-W9B transplantable mammary tumor in the rat. , 1982, Journal of the National Cancer Institute.

[16]  A. Manni,et al.  Uterine oestrogen and progesterone receptors in the ovariectomized rat. , 1981, The Journal of endocrinology.

[17]  B. Komisaruk,et al.  Differential effects of testosterone and dihydrotestosterone on the diverse uterine tissues of the ovariectomized rat. , 1972, Endocrinology.

[18]  W. Wiest,et al.  Progesterone "receptor" in rabbit uterus. I. Characterization and estradiol-17beta augmentation. , 1973, Endocrinology.

[19]  K. Larsson,et al.  Inhibition of testosterone-induced sexual behavior in the castrated male rat by aromatase blockers , 1977, Hormones and Behavior.

[20]  D. Chalbos,et al.  Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture. , 1983, The Journal of clinical endocrinology and metabolism.

[21]  C. Monder,et al.  In Vitro Metabolism of 7α-Methyl-19-Nortestosterone by Rat Liver, Prostate, and Epididymis , 1988 .

[22]  M. Dumont,et al.  Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line. , 1989, Endocrinology.

[23]  M. Lyon,et al.  Evidence from Tfm/0 that Androgen is Inessential for Reproduction in Female Mice , 1974, Nature.

[24]  J. Gaillard,et al.  Different in vitro metabolism of 7 α-methyl-19-nortestosterone by human and equine aromatases , 1993 .

[25]  C. Lyttle,et al.  Uterine peroxidase as a marker for estrogen action. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Giannopoulos Binding of testosterone to cytoplasmic components of the immature rat uterus. , 1971, Biochemical and biophysical research communications.

[27]  F. Larrea,et al.  Nuclear translocation of estradiol receptors by the in vivo administration of norethisterone: an alternate mechanism for gonadotropin inhibition. , 1983, Journal of steroid biochemistry.

[28]  R. Wood,et al.  7α-Methyl-19-nortestosterone Facilitates Sexual Behavior in the Male Syrian Hamster , 1996, Hormones and Behavior.

[29]  C. Bardin,et al.  Aromatization of 7α-Methyl-19-nortestosterone by human placental microsomes in vitro , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[30]  J. Kato,et al.  Androgen receptor mRNA in the rat ovary and uterus , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[31]  L. Lerner,et al.  Effects of hormone antagonists on morphological and biochemical changes induced by hormonal steroids in the immature rat uterus. , 1966, Endocrinology.

[32]  A. Gompel,et al.  Antiestrogen action of progesterone in breast tissue. , 1987, Hormone research.

[33]  K. Korach,et al.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.

[34]  Chawnshang Chang,et al.  Immunohistochemical localization of androgen receptors with mono- and polyclonal antibodies to androgen receptor. , 1990, The Journal of endocrinology.

[35]  J. Wilson,et al.  Estrogen and androgen production rates in two brothers with Reifenstein syndrome. , 1990, The Journal of clinical endocrinology and metabolism.

[36]  D. Pfaff,et al.  Effects of Testosterone and 7α-Methyl-19-Nortestosterone (MENT) on Sexual and Aggressive Behaviors in Two Inbred Strains of Male Mice , 1996, Hormones and Behavior.

[37]  E. Baulieu,et al.  Mechanisms regulating the concentration and the conformation of progesterone receptor(s) in the uterus. , 1973, The Journal of biological chemistry.

[38]  C. Bardin,et al.  The biological activity of 7 alpha-methyl-19-nortestosterone is not amplified in male reproductive tract as is that of testosterone. , 1992, Endocrinology.